580 related articles for article (PubMed ID: 25281316)
21. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
Niibori Y; Lee SJ; Minassian BA; Hampson DR
Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
[TBL] [Abstract][Full Text] [Related]
22. Synaptic Integration in CA1 Pyramidal Neurons Is Intact despite Deficits in GABAergic Transmission in the
Chancey JH; Howard MA
eNeuro; 2022; 9(3):. PubMed ID: 35523580
[TBL] [Abstract][Full Text] [Related]
23. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
Elife; 2016 Jul; 5():. PubMed ID: 27458797
[TBL] [Abstract][Full Text] [Related]
24. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
[TBL] [Abstract][Full Text] [Related]
25. Scn1a gene reactivation after symptom onset rescues pathological phenotypes in a mouse model of Dravet syndrome.
Valassina N; Brusco S; Salamone A; Serra L; Luoni M; Giannelli S; Bido S; Massimino L; Ungaro F; Mazzara PG; D'Adamo P; Lignani G; Broccoli V; Colasante G
Nat Commun; 2022 Jan; 13(1):161. PubMed ID: 35013317
[TBL] [Abstract][Full Text] [Related]
26. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
27. Purinergic control of hippocampal circuit hyperexcitability in Dravet syndrome.
Gu F; Hazra A; Aulakh A; Žiburkus J
Epilepsia; 2014 Feb; 55(2):245-55. PubMed ID: 24417577
[TBL] [Abstract][Full Text] [Related]
28. A selective Na
Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
[TBL] [Abstract][Full Text] [Related]
29. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
30. Interneuron Desynchronization Precedes Seizures in a Mouse Model of Dravet Syndrome.
Tran CH; Vaiana M; Nakuci J; Somarowthu A; Goff KM; Goldstein N; Murthy P; Muldoon SF; Goldberg EM
J Neurosci; 2020 Mar; 40(13):2764-2775. PubMed ID: 32102923
[TBL] [Abstract][Full Text] [Related]
31. Adolescent behavioral abnormalities in a Scn1a
Bahceci D; Anderson LL; Occelli Hanbury Brown CV; Zhou C; Arnold JC
Epilepsy Behav; 2020 Feb; 103(Pt A):106842. PubMed ID: 31870807
[TBL] [Abstract][Full Text] [Related]
32. Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.
Dutton SBB; Dutt K; Papale LA; Helmers S; Goldin AL; Escayg A
Exp Neurol; 2017 Jul; 293():159-171. PubMed ID: 28373025
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
Goff KM; Goldberg EM
Elife; 2019 Jul; 8():. PubMed ID: 31282864
[TBL] [Abstract][Full Text] [Related]
34. Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome.
Liautard C; Scalmani P; Carriero G; de Curtis M; Franceschetti S; Mantegazza M
Epilepsia; 2013 Jul; 54(7):1251-61. PubMed ID: 23663038
[TBL] [Abstract][Full Text] [Related]
35. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.
Anderson LL; Hawkins NA; Thompson CH; Kearney JA; George AL
Sci Rep; 2017 May; 7(1):1682. PubMed ID: 28490751
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K
Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790
[TBL] [Abstract][Full Text] [Related]
37. Preictal dysfunctions of inhibitory interneurons paradoxically lead to their rebound hyperactivity and to low-voltage-fast onset seizures in Dravet syndrome.
Capitano F; Kuchenbuch M; Lavigne J; Chaptoukaev H; Zuluaga MA; Lorenzi M; Nabbout R; Mantegazza M
Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2316364121. PubMed ID: 38809712
[TBL] [Abstract][Full Text] [Related]
38. Epilepsy channelopathies go neddy: stabilizing NaV1.1 channels by neddylation.
Cannon SC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855971
[TBL] [Abstract][Full Text] [Related]
39. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
